Testing a new method for diagnosing vestibular disorders using vibration.
Diagnostic Precision Study on Vibration Induced Nystagmus Test for SCDS by Ortofone
NA · Region Stockholm · NCT05967065
This study is testing a new way to diagnose balance disorders, like Meniere's disease, by using vibrations to see how patients' eyes respond compared to healthy individuals.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Region Stockholm (other gov) |
| Locations | 1 site (Stockholm) |
| Trial ID | NCT05967065 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of the vibration induced nystagmus test using the Ortofone B250 bone transducer to assess patients with vestibular disorders, including Superior Canal Dehiscence Syndrome and Meniere's disease. It compares the videonystagmography responses of affected patients to those of healthy control subjects. The goal is to enhance diagnostic precision for these conditions through innovative testing methods.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with specific vestibular disorders such as Superior Canal Dehiscence Syndrome and Meniere's disease.
Not a fit: Patients experiencing vertigo and dizziness without a specific diagnosis may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate diagnoses for patients with vestibular disorders, improving treatment outcomes.
How similar studies have performed: While this approach is innovative, similar studies have shown promise in enhancing diagnostic techniques for vestibular disorders.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients affected by certain vestibular disorders. Exclusion Criteria: Patients with vertigo and dizziness without certain diagnosis.
Where this trial is running
Stockholm
- Karolinska University Hospital, Hearing and Balance Unit — Stockholm, Sweden (RECRUITING)
Study contacts
- Study coordinator: Luca Verrecchia, MD PhD
- Email: luca.verrecchia@ki.se
- Phone: +46724654523
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Superior Canal Dehiscence Syndrome, Vestibular Disorder